Levita Magnetics' new platform provides a clinical benefit to patients, better visualization and control to surgeons, and higher efficiency to hospitals.
In a pilot study treating refractory epilepsy with Neuroelectrics’ Starstim platform, patients experienced a 44 percent median reduction in seizure frequency.